Isotonix維生素D(含維生素K2)粉末 - 單瓶裝(30份)
- 由: Market America
- 產品代號: 13071




$33.50 USD
Isotonix維生素 D(含維生素K2)粉末含有維生素D3(具代謝活性的維生素D形式)和維生素K2(支援血管健康和鈣利用的維生素K形式)。維生素D對於骨骼健康、心臟健康和免疫支援有重要作用;與維生素K共同使用,可支援鈣的正常吸收並促進動脈健康。 Isotonix Vitamin D維生素D是首個以等滲透方式同時提供這兩種強效維生素的產品。Isotonix維生素D3(含維生素K2)粉末中加入維生素K是因為維生素K和D配合作用效果顯著,可共同支援鈣的吸收和利用。維生素K支援鈣正常傳輸到骨骼,並促進動脈健康。科學家已發現至少兩種以天然形式存在的維生素K,命名為K1和K2。雖然維生素K的這兩種形式有許多相似之處,但也有一些重要的區別。 維生素K1和K2最顯著的區別在於化學結構,導致它們具有不同的藥動學特性。維生素K1主要存留在肝臟中,高劑量時可能會干擾華法林(warfarin)和其他抗凝血藥物的作用。維生素K2的作用機制不同於K1,它主要傳輸至骨骼和血管。維生素K2有助維持骨量、支援鈣的利用和促進血管彈性。一些研究結論表明維生素K2不會對抗凝血藥物造成影響。* 但是,大多數含有維生素K(包括K1及/或K2)的產品都有警告標示,提醒服用抗凝血藥物的人不要使用此類產品。如果您正在服用華法林或其他抗凝血藥物,在使用任何含有維生素K1或K2的產品前,請先諮詢您的醫護人員。相關詞:維生素D,維生素K,骨骼健康,心血管健康,免疫支援,D3,K2
此產品符合減免運費。
產品詳細資料益處
- 促進正常的骨骼礦物密度
- 促進動脈的健康
- 支援免疫系統健康
- 有助維持骨骼健康
- 維持正常蝕骨細胞活動以維護骨量
- 幫助維持心血管健康
- 促進血管彈性
- 有助維持正常血壓
- 骨質密度低的女性被發現缺乏維生素K
為什麼選擇Isotonix Vitamin D 維生素D?
Isotonix維生素 D(含維生素K2)粉末含有維生素D3(具代謝活性的維生素D形式)和維生素K2(支援血管健康和鈣利用的維生素K形式)。維生素D對於骨骼健康、心臟健康和免疫支援有重要作用;與維生素K共同使用,可支援鈣的正常吸收並促進動脈健康。
Isotonix Vitamin D維生素D是首個以等滲透方式同時提供這兩種強效維生素的產品。Isotonix Vitamin D3 with K2維生素D3(含維生素K2)粉末中加入維生素K是因為維生素K和D配合作用效果顯著,可共同支援鈣的吸收和利用。維生素K支援鈣正常傳輸到骨骼,並促進動脈健康。科學家已發現至少兩種以天然形式存在的維生素K,命名為K1和K2。雖然維生素K的這兩種形式有許多相似之處,但也有一些重要的區別。
維生素K1和K2最顯著的區別在於化學結構,導致它們具有不同的藥動學特性。維生素K1主要存留在肝臟中,高劑量時可能會干擾華法林(warfarin)和其他抗凝血藥物的作用。維生素K2的作用機制不同於K1,它主要傳輸至骨骼和血管。維生素K2有助維持骨量、支援鈣的利用和促進血管彈性。一些研究結論表明維生素K2不會對抗凝血藥物造成影響。*
但是,大多數含有維生素K(包括K1和/或K2)的產品都有警告標示,提醒服用抗凝血藥物的人不要使用此類產品。如果您正在服用華法林或其他抗凝血藥物,在使用任何含有維生素K1或K2的產品前,請先咨詢您的醫護人員。相關詞:維生素D,維生素K,骨骼健康,心血管健康,免疫支援,D3,K2
成分
常見問答
科學
Hidaka T et al. Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: effects of concomitant administration of vitamin K(2). Journal of Bone and Mineral Metabolism. 20(4):235-239, 2002. · Iwamoto J et al. Effects of vitamin K2 on osteoporosis. Current Pharmaceutical Design. 10(21):2557-2576, 2004. · Iwamoto J et al. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis. The Keio Journal of Medicine. 2003 Sep;52(3):147-50. Review. · Neogi, T., et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis and Rheumatism. 54(4):1255-1261, 2006.
Price P. Role of vitamin K-dependent proteins in bone metabolism. Annual Review of Nutrition. 8:565-583, 1988. · Bekner K. The vitamin K-dependent carboxylase. Journal of Nutrition. 130(8):1877-1880, 2000. · Nelsestuen G et al. Vitamin K-dependent proteins. Vitamins and Hormones. 58:355-389, 2000. · Shearer M. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Current Opinion in Clinical Nutrition and Metabolic Care. 3(6):433-438, 2000. · Gundberg C et al. Vitamin K status and bone health: an analysis of methods for determination under carboxylated osteocalcin. Journal of Clinical Endocrinology and Metabolism. 83(9):3258-3266, 1998. · Weber P. Management of osteoporosis: is there a role for vitamin K? International Journal for Vitamin and Nutrition Research. 67(5):350-6, 1997. · Garber, A. K., et al. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. Journal of Nutrition. 129(6):1201-1203, 1999. · Binkley N et al. Vitamin K nutrition and osteoporosis. Journal of Nutrition. 125(7):1812-1821, 1995. · Bischoff-Ferrari Het al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 293(18):2257-2264, 2005. · Guirguis-Blake J et al. Oral vitamin D3 decreases fracture risk in the elderly. Journal of Family Practice. 52(6):431-435, 2003. · Schaafsma, A., et al. Vitamin D3 and vitamin K1 supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. European Journal of Clinical Nutrition. 54:626-631, 2000. · Trivedi Det al. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal. 326(7387):469, 2003. · Van den Berghe G et al. Bone turnover in prolonged critical illness: effect of vitamin D. Journal of Clinical Endocrinology and Metabolism. 88(10):4623-4632, 2003. · Chapuy M et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. New England Journal of Medicine. 327(23):1637-1642, 1992. · Grant W and Holick M. Benefits and requirements of vitamin D for optimal health. Alternative Medicine Review. 10:94-111, 2005. · Plaza S and La · Zitterman A et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology. 41(1):105-112, 2003. · Schleithoff S et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition. 83(4):754-759, 2006.
Argiles A et al. Blood pressure is correlated with vitamin D(3) serum levels in dialysis patients. Blood Purification. 20(4):370-375, 2002. · Kristal-Boneh E et al. Association of calcitriol and blood pressure in normotensive men. Hypertension. 30(5):1289-1294, 1997. · Li Y et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation. 110(2):229-238, 2002. · Li Y et al. Vitamin D regulation of the renin-angiotensin system. Journal of Cell Biochemistry. 88(2):327-331, 2003. · Li Y et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5):387-392, 2004. · Pfeifer M et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. Journal of Clinical Endocrinology and Metabolism. 86(4):1633-1637, 2001. · Sigmund C. Regulation of renin expression and blood pressure by vitamin D(3). Journal of Clinical Investigation. 110(2):155-156, 2002.
Vasquez A et al. The clinical importance of vitamin D (cholecalciferol): a paradigm shift with implications for all healthcare providers. Alternative Therapies. 10(5):28-38, 2004. · Nimptsch K et al. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition. American Journal of Clinical Nutrition. 87:985-992, 2008. · Habu D et al. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA. 292(3):358-361, 2004. · Yoshida T et al. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. International Journal of Oncology. 23(3):627-632, 2003. · La
Yokoyama T et al. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines. International Journal of Oncology. 26(1):33-40, 2005. · Chlebowski R et al. Vitamin K in the treatment of cancer. Cancer Treatment Review. 12:49-63, 1985. · La · Hitomi M et al. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. International Journal of Oncology. 26(3):713-720, 2005. · Nouso K et al. Regression of hepatocellular carcinoma during vitamin K administration. World Journal of Gastroenterology. 11(42):6722-6724, 2005. · Blackmore K et al. Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. American Journal of Epidemiology. 168(8):915-24, 2008. · Deluca H et al. Vitamin D: its role and uses in immunology. FASEB Journal. 15(14):2579-2585, 2001.
Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. International Immunopharmacology. 2(7):1017-1028, 2002. · Cantorna M et al. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Experimental Biology and Medicine ( Maywood ). 229(11):1136-1142, 2004. · Cantorna M. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Society for Experimental Biology and Medicine. 223:230-233, 2000. · Garland C et al. The role of vitamin D in cancer prevention. American Journal of Public Health. 96(2):252-61, 2006. · Giovannucci E et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. Journal of the National Cancer Institute. 98(7):451-459, 2006. · Holick, M. Vitamin D: Its role in cancer prevention and treatment. Progress in Biophysics and Molecular Biology. 92(1):49-59, 2006. · Gorham E et al. Vitamin D and prevention of colorectal cancer. Journal Steroid Biochemistry and Molecular Biology. 97(1-2):179-94, 2005. · Grant W et al. Reviews: A critical review of studies on vitamin D in relation to colorectal cancer. Nutrition and Cancer. 48(2):115-123, 2004. · Harris D et al. Vitamin D and colon carcinogenesis. Journal of Nutrition. 134(12):3463S-3471S, 2004. · Hayes C et al. The immunological functions of the vitamin D endocrine system. Cellular and Molecular Biology. 49(2):277-300, 2003.
* 有關產品的陳述未經食品與藥物管理局評估。
此產品無意作為診斷、治療或預防疾病之用。